The Choice of Treatment in Ischemic Mitral Regurgitation With Reduced Left Ventricular Function

Francesco Nappi, Sanjeet Singh Avtaar Singh, Muralidhar Padala, David Attias, Mohammed Nejjari, Christos G. Mihos, Umberto Benedetto, Robert Michler

Research output: Contribution to journalReview article

Abstract

Background: Ischemic mitral regurgitation is a condition characterized by mitral insufficiency secondary to an ischemic left ventricle. Primarily, the pathology is the result of perturbation of normal regional left ventricular geometry combined with adverse remodeling. We present a comprehensive review of contemporary surgical, medical, and percutaneous treatment options for ischemic mitral regurgitation, rigorously examined by current guidelines and literature. Methods: We conducted a literature search of the PubMed database, Embase, and the Cochrane Library (through November 2018) for studies reporting perioperative or late mortality and echocardiographic outcomes after surgical and nonsurgical intervention for ischemic mitral regurgitation. Results: Treatment of this condition is challenging and often requires a multimodality approach. These patients usually have multiple comorbidities that may preclude surgery as a viable option. A multidisciplinary team discussion is crucial in optimizing outcomes. There are several options for treatment and management of ischemic mitral regurgitation with differing benefits and risks. Guideline-directed medical therapy for heart failure is the treatment choice for moderate and severe ischemic mitral regurgitation, with consideration of coronary revascularization, mitral valve surgery, cardiac resynchronization therapy, or a combination of these, in appropriate candidates. The use of transcatheter mitral valve therapy is considered appropriate in high-risk patients with severe ischemic mitral regurgitation, heart failure, and reduced left ventricular ejection fraction, especially in those with hemodynamic instability. Conclusions: The role of mitral valve surgery and transcatheter mitral valve therapy continues to evolve.

Original languageEnglish (US)
Pages (from-to)1901-1912
Number of pages12
JournalAnnals of Thoracic Surgery
Volume108
Issue number6
DOIs
StatePublished - Dec 2019

Fingerprint

Mitral Valve Insufficiency
Left Ventricular Function
Mitral Valve
Therapeutics
Heart Failure
Guidelines
Cardiac Resynchronization Therapy
PubMed
Stroke Volume
Libraries
Heart Ventricles
Comorbidity
Hemodynamics
Databases
Pathology
Mortality

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

The Choice of Treatment in Ischemic Mitral Regurgitation With Reduced Left Ventricular Function. / Nappi, Francesco; Avtaar Singh, Sanjeet Singh; Padala, Muralidhar; Attias, David; Nejjari, Mohammed; Mihos, Christos G.; Benedetto, Umberto; Michler, Robert.

In: Annals of Thoracic Surgery, Vol. 108, No. 6, 12.2019, p. 1901-1912.

Research output: Contribution to journalReview article

Nappi, F, Avtaar Singh, SS, Padala, M, Attias, D, Nejjari, M, Mihos, CG, Benedetto, U & Michler, R 2019, 'The Choice of Treatment in Ischemic Mitral Regurgitation With Reduced Left Ventricular Function', Annals of Thoracic Surgery, vol. 108, no. 6, pp. 1901-1912. https://doi.org/10.1016/j.athoracsur.2019.06.039
Nappi, Francesco ; Avtaar Singh, Sanjeet Singh ; Padala, Muralidhar ; Attias, David ; Nejjari, Mohammed ; Mihos, Christos G. ; Benedetto, Umberto ; Michler, Robert. / The Choice of Treatment in Ischemic Mitral Regurgitation With Reduced Left Ventricular Function. In: Annals of Thoracic Surgery. 2019 ; Vol. 108, No. 6. pp. 1901-1912.
@article{af9fc48b39f4485dabe3dbd9b8b0d15e,
title = "The Choice of Treatment in Ischemic Mitral Regurgitation With Reduced Left Ventricular Function",
abstract = "Background: Ischemic mitral regurgitation is a condition characterized by mitral insufficiency secondary to an ischemic left ventricle. Primarily, the pathology is the result of perturbation of normal regional left ventricular geometry combined with adverse remodeling. We present a comprehensive review of contemporary surgical, medical, and percutaneous treatment options for ischemic mitral regurgitation, rigorously examined by current guidelines and literature. Methods: We conducted a literature search of the PubMed database, Embase, and the Cochrane Library (through November 2018) for studies reporting perioperative or late mortality and echocardiographic outcomes after surgical and nonsurgical intervention for ischemic mitral regurgitation. Results: Treatment of this condition is challenging and often requires a multimodality approach. These patients usually have multiple comorbidities that may preclude surgery as a viable option. A multidisciplinary team discussion is crucial in optimizing outcomes. There are several options for treatment and management of ischemic mitral regurgitation with differing benefits and risks. Guideline-directed medical therapy for heart failure is the treatment choice for moderate and severe ischemic mitral regurgitation, with consideration of coronary revascularization, mitral valve surgery, cardiac resynchronization therapy, or a combination of these, in appropriate candidates. The use of transcatheter mitral valve therapy is considered appropriate in high-risk patients with severe ischemic mitral regurgitation, heart failure, and reduced left ventricular ejection fraction, especially in those with hemodynamic instability. Conclusions: The role of mitral valve surgery and transcatheter mitral valve therapy continues to evolve.",
author = "Francesco Nappi and {Avtaar Singh}, {Sanjeet Singh} and Muralidhar Padala and David Attias and Mohammed Nejjari and Mihos, {Christos G.} and Umberto Benedetto and Robert Michler",
year = "2019",
month = "12",
doi = "10.1016/j.athoracsur.2019.06.039",
language = "English (US)",
volume = "108",
pages = "1901--1912",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - The Choice of Treatment in Ischemic Mitral Regurgitation With Reduced Left Ventricular Function

AU - Nappi, Francesco

AU - Avtaar Singh, Sanjeet Singh

AU - Padala, Muralidhar

AU - Attias, David

AU - Nejjari, Mohammed

AU - Mihos, Christos G.

AU - Benedetto, Umberto

AU - Michler, Robert

PY - 2019/12

Y1 - 2019/12

N2 - Background: Ischemic mitral regurgitation is a condition characterized by mitral insufficiency secondary to an ischemic left ventricle. Primarily, the pathology is the result of perturbation of normal regional left ventricular geometry combined with adverse remodeling. We present a comprehensive review of contemporary surgical, medical, and percutaneous treatment options for ischemic mitral regurgitation, rigorously examined by current guidelines and literature. Methods: We conducted a literature search of the PubMed database, Embase, and the Cochrane Library (through November 2018) for studies reporting perioperative or late mortality and echocardiographic outcomes after surgical and nonsurgical intervention for ischemic mitral regurgitation. Results: Treatment of this condition is challenging and often requires a multimodality approach. These patients usually have multiple comorbidities that may preclude surgery as a viable option. A multidisciplinary team discussion is crucial in optimizing outcomes. There are several options for treatment and management of ischemic mitral regurgitation with differing benefits and risks. Guideline-directed medical therapy for heart failure is the treatment choice for moderate and severe ischemic mitral regurgitation, with consideration of coronary revascularization, mitral valve surgery, cardiac resynchronization therapy, or a combination of these, in appropriate candidates. The use of transcatheter mitral valve therapy is considered appropriate in high-risk patients with severe ischemic mitral regurgitation, heart failure, and reduced left ventricular ejection fraction, especially in those with hemodynamic instability. Conclusions: The role of mitral valve surgery and transcatheter mitral valve therapy continues to evolve.

AB - Background: Ischemic mitral regurgitation is a condition characterized by mitral insufficiency secondary to an ischemic left ventricle. Primarily, the pathology is the result of perturbation of normal regional left ventricular geometry combined with adverse remodeling. We present a comprehensive review of contemporary surgical, medical, and percutaneous treatment options for ischemic mitral regurgitation, rigorously examined by current guidelines and literature. Methods: We conducted a literature search of the PubMed database, Embase, and the Cochrane Library (through November 2018) for studies reporting perioperative or late mortality and echocardiographic outcomes after surgical and nonsurgical intervention for ischemic mitral regurgitation. Results: Treatment of this condition is challenging and often requires a multimodality approach. These patients usually have multiple comorbidities that may preclude surgery as a viable option. A multidisciplinary team discussion is crucial in optimizing outcomes. There are several options for treatment and management of ischemic mitral regurgitation with differing benefits and risks. Guideline-directed medical therapy for heart failure is the treatment choice for moderate and severe ischemic mitral regurgitation, with consideration of coronary revascularization, mitral valve surgery, cardiac resynchronization therapy, or a combination of these, in appropriate candidates. The use of transcatheter mitral valve therapy is considered appropriate in high-risk patients with severe ischemic mitral regurgitation, heart failure, and reduced left ventricular ejection fraction, especially in those with hemodynamic instability. Conclusions: The role of mitral valve surgery and transcatheter mitral valve therapy continues to evolve.

UR - http://www.scopus.com/inward/record.url?scp=85075265117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075265117&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2019.06.039

DO - 10.1016/j.athoracsur.2019.06.039

M3 - Review article

C2 - 31445916

AN - SCOPUS:85075265117

VL - 108

SP - 1901

EP - 1912

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 6

ER -